Characterization of the inflammatory tumor microenvironment composition in solid cancer patients with brain metastases after progression to immune checkpoint inhibitor therapy

被引：0
|
作者：
Starzer, A. M. [1 ,2 ]
Kleinberger, M. [1 ]
Feldmann, K. [1 ,2 ]
Tomasich, E. [1 ,2 ]
Hatziioannou, T. [1 ,2 ]
Paiato, C. [1 ,2 ]
Heller, G. [1 ,2 ]
Kreminger, J. [1 ,2 ]
Traint, S. [1 ,2 ]
Steindl, A. [1 ,2 ]
Ressler, J. M. [3 ]
Widhalm, G. [4 ]
Gatterbauer, B. [4 ]
Dieckmann, K. [5 ]
Mullauer, L. [6 ]
Preusser, M. [1 ,2 ]
Berghoff, A. S. [1 ]
机构：
[1] Med Univ Vienna, Div Oncol, Vienna, Austria
[2] Christian Doppler Lab Personalized Immunotherapy, Vienna, Austria
[3] Med Univ Vienna, Dept Dermatol, Vienna, Austria
[4] Med Univ Vienna, Dept Neurosurg, Vienna, Austria
[5] Med Univ Vienna, Dept Radiotherapy, Vienna, Austria
[6] Med Univ Vienna, Dept Pathol, Vienna, Austria
来源：
NEURO-ONCOLOGY | 2022年 / 24卷
关键词：
D O I：
10.1093/neuonc/noac174.037
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OS03.5.A
引用
收藏
页数：1
相关论文
共 50 条
  • [1] The inflammatory tumor microenvironment in patients with solid tumors with brain metastases after progression to immune checkpoint inhibitor therapy
    Starzer, A. M.
    Kleinberger, M.
    Feldmann, K.
    Tomasich, E.
    Hatziioannou, T.
    Paiato, C.
    Heller, G.
    Kreminger, J.
    Traint, S.
    Steindl, A.
    Ressler, J. M.
    Widhalm, G.
    Gatterbauer, B.
    Dieckmann, K.
    Muellauer, L.
    Preusser, M.
    Berghoff, A. S.
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 2) : 272 - 272
  • [2] Characterization of the inflammatory tumor microenvironment composition in brain metastases after failure of immune checkpoint inhibitor therapy
    Starzer, A. M.
    Kleinberger, M.
    Feldmann, K.
    Kreminger, J.
    Traint, S.
    Steindl, A.
    Widhalm, G.
    Gatterbauer, B.
    Dieckmann, K.
    Preusser, M.
    Berghoff, A. S.
    ANNALS OF ONCOLOGY, 2021, 32 : S525 - S525
  • [3] Analysis of Tumor Microenvironment Characteristics in Bladder Cancer: Implications for Immune Checkpoint Inhibitor Therapy
    Chen, Xingyu
    Chen, Haotian
    He, Dong
    Cheng, Yaxin
    Zhu, Yuxing
    Xiao, Mengqing
    Lan, Hua
    Wang, Zhanwang
    Cao, Ke
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [4] Immune Checkpoint Inhibitor Therapy for Bone Metastases: Specific Microenvironment and Current Situation
    Liu, Chang
    Wang, Miao
    Xu, Changli
    Li, Bo
    Chen, Juxiang
    Chen, Jianchun
    Wang, Zhiwei
    JOURNAL OF IMMUNOLOGY RESEARCH, 2021, 2021
  • [5] Control of renal cell carcinoma brain metastases with cabozantinib following progression on immune checkpoint inhibitor therapy
    Hong, Cierra
    Batich, Kristen A.
    Almquist, Garland
    Villa, Luis
    George, Daniel J.
    Zhang, Tian
    CURRENT PROBLEMS IN CANCER: CASE REPORTS, 2021, 3
  • [6] Tumor Immune Microenvironment in Cancer Progression and Cancer Therapy Preface
    Kalinski, Pawel
    TUMOR IMMUNE MICROENVIRONMENT IN CANCER PROGRESSION AND CANCER THERAPY, 2017, 1036 : V - VI
  • [7] Characterization of Biomarkers to Immune Checkpoint Inhibitor Therapy in Solid Tumors
    Huang, Xiu
    Russell, Meaghan K.
    Pantazi, Angeliki
    Lvova, Maria
    Vuzman, Dana
    Lyle, Stephen
    Tse, Julie Y.
    LABORATORY INVESTIGATION, 2018, 98 : 701 - 701
  • [8] Characterization of Biomarkers to Immune Checkpoint Inhibitor Therapy in Solid Tumors
    Huang, Xiu
    Russell, Meaghan K.
    Pantazi, Angeliki
    Lvova, Maria
    Vuzman, Dana
    Lyle, Stephen
    Tse, Julie Y.
    MODERN PATHOLOGY, 2018, 31 : 701 - 701
  • [9] Outcomes of melanoma patients with brain metastases receiving immune checkpoint inhibitor (ICI) therapy.
    Ardeshir-Larijani, Fatemeh
    Nelson, Ariel Ann
    Martin, Petra
    Mendiratta, Prateek
    Sloan, Andrew E.
    Choi, Serah
    Mansur, David B.
    Hoimes, Christopher J.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [10] Characterization of the immune microenvironment in brain metastases from different solid tumors
    Jiang, Jinling
    Wu, Lihong
    Yuan, Fei
    Ji, Jun
    Lin, Xiaojing
    Yang, Wanning
    Wu, Junwei
    Shi, Min
    Yang, Hui
    Ma, Yanna
    Song, Xue
    Zhu, Zhenggang
    Zhang, Henghui
    Zhang, Jun
    CANCER MEDICINE, 2020, 9 (07): : 2299 - 2308
12345